Skip to content

Clinical trials

Phase 3 Skin Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Diseases Phase: Phase 3 Country / region: Canada Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20104
20121
20133
20171
20182
20193
20205
20212
20235
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting3
Withdrawn2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Incyte Corporation6
Amgen5
Pfizer4
MoonLake Immunotherapeutics AG3
Galderma R&D2
Novartis Pharmaceuticals2
AstraZeneca1
Graceway Pharmaceuticals, LLC1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Diseases32
Dermatitis11
Eczema10
Dermatitis, Atopic8
Psoriasis6
Hidradenitis Suppurativa5
Arthritis4
Arthritis, Psoriatic4
Inflammation4
Prurigo4

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.